Mazzenga, Marine
Inserm · Institut Gustave Roussy · La Ligue Contre le Cancer
2 papers on CoChatORCID 0000-0003-2441-0541
Most cited papers
- Verified
Escherichia coli –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Goubet, A.-G., Lordello, L., Alves Costa Silva, C., Peguillet, I., Gazzano, M., Mbogning-Fonkou, M. D., Thelemaque, C., Lebacle, C., Thibault, C., Audenet, F., et al. (2022) · Cancer Discovery
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 86
- Verified
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
Terrisse, S., Goubet, A.-G., Ueda, K., Thomas, A. M., Quiniou, V., Thelemaque, C., Dunsmore, G., Clave, E., Gamat-Huber, M., Yonekura, S., et al. (2022) · Journal for ImmunoTherapy of Cancer
Prostate Cancer Treatment and ResearchGut microbiota and health
Cited by 80
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free